Reference
Scottish Medicines Consortium. SMC advice: budesonide (Budenofalk); budesonide (Budenofalk) Abbreviated; ceftaroline fosamil (Zinforo); clostridium botulinum toxin A (Dysport); dapagliflozin (Forxiga); glycopyrronium (Seebri Breezhaler); ivacaftor (Kalydeco); vildagliptin (Galvus). Internet Document : 14 Jan 2013. Available from: URL: http://www.scottishmedicines.org.uk
Rights and permissions
About this article
Cite this article
Recent decisions from the SMC. PharmacoEcon Outcomes News 670, 11 (2013). https://doi.org/10.1007/s40274-013-0112-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0112-4